Double Blind Bio
San Francisco, US · Founded 2025 · Delaware corporation · 3 known investors
Find your way into Double Blind Bio
Double Blind Bio builds AI agents that automate administrative workflows within clinical trial sites and sponsor operations, enabling faster and more efficient execution of clinical studies. The company targets research sites and trial sponsors who seek to reduce repetitive work and accelerate patient access to new treatments.
Founders & leadership
DH
David HughesNamed on SEC filing
ST
Shruti TibrewalaNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 1 round · 2025
▶$5.6MraisedDec 2025 · 6 investors · Other TechnologyRule 506(b)
▶$5.6MraisedDec 2025 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David HughesExecutive Officer, Director
- Shruti TibrewalaExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Double Blind Bio do?
- Double Blind Bio builds AI agents that automate administrative workflows within clinical trial sites and sponsor operations, enabling faster and more efficient execution of clinical studies. The company targets research sites and trial sponsors who seek to reduce repetitive work and accelerate patient access to new treatments.
- Who are Double Blind Bio's investors?
- Double Blind Bio's investors include Define Ventures, Peterson Ventures, SignalFire.
- How much funding has Double Blind Bio raised?
- Double Blind Bio has disclosed $5.6M raised across 1 round.
- Where is Double Blind Bio headquartered?
- Double Blind Bio is headquartered in San Francisco, US.